IOVANCE BIOTHERAPEUTICS, INC. - FORM 10-K - EX-32.1 - EXHIBIT 32.1 - March 27, 2014

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - IOVANCE BIOTHERAPEUTICS, INC.Financial_Report.xls
EX-31.2 - EXHIBIT 31.2 - IOVANCE BIOTHERAPEUTICS, INC.ex312.htm
EX-32.2 - EXHIBIT 32.2 - IOVANCE BIOTHERAPEUTICS, INC.ex322.htm
EX-31.1 - EXHIBIT 31.1 - IOVANCE BIOTHERAPEUTICS, INC.ex311.htm
10-K - LION BIOTECHNOLOGIES, INC. ANNUAL REPORT - IOVANCE BIOTHERAPEUTICS, INC.lion10k2013.htm
EX-10.41 - EXECUTIVE EMPLOYMENT AGREEMENT DATED JULY 24, 2013 BETWEEN THE COMPANY AND MANISH SINGH - IOVANCE BIOTHERAPEUTICS, INC.ex1041.htm

EXHIBIT 32.1

CERTIFICATION TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, I, Manish Singh, Chief Executive Officer of Lion Biotechnologies, Inc. (the “Company”), hereby certify that, to the best of my knowledge:

(i) the Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
     
       
Date: March 27, 2014
By:
/s/ MANISH SINGH  
    Name: Manish Singh  
    Title: Chief Executive Officer (Principal Executive Officer)  
       

IOVANCE BIOTHERAPEUTICS, INC. Reports

Also read